Trial
NCT02677350
AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Joshua M Hare
Collaborators
—
Condition
Crohn's Disease
Intervention
Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)
Why stopped
Study is permanently closed to enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-27